The research carried out at the IRCAN involves major areas of biology, from basic research to medical applications, with the objectives of improving our understanding of the common foundation between aging and cancer, and developing innovative strategies to prevent and cure cancer and chronic age-related pathologies. To ensure the excellence of our research, the IRCAN benefits from a strong and international scientific advisory board composed, amongst other eminent and internationally recognised scientists, of Tomas Lindahl (London, Uk) that was awarded the Nobel Prize in Chemistry in 2015.